Praechompoo Pongtornpipat
Overview
Explore the profile of Praechompoo Pongtornpipat including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
94
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dower W, Park A, Bakker A, Cwirla S, Pongtornpipat P, Williams B, et al.
PLoS One
. 2023 Oct;
18(10):e0286834.
PMID: 37874823
Interleukin (IL)-7 is broadly active on T-cell populations, and modified versions have been clinically evaluated for a variety of therapeutic applications, including cancer, lymphopenia, and infectious diseases; and found to...
2.
Peters T, Tillotson J, Yeomans A, Wilmore S, Lemm E, Jimenez-Romero C, et al.
Clin Cancer Res
. 2018 May;
24(17):4256-4270.
PMID: 29844128
The DEAD-box RNA helicase eIF4A1 carries out the key enzymatic step of cap-dependent translation initiation and is a well-established target for cancer therapy, but no drug against it has entered...
3.
Peters T, Li L, Tula-Sanchez A, Pongtornpipat P, Schatz J
Oncotarget
. 2016 Aug;
7(39):63362-63373.
PMID: 27556513
The PIM family kinases promote growth and survival of tumor cells and are expressed in a wide variety of human cancers. Their potential as therapeutic targets, however, is complicated by...
4.
Amin A, Li L, Rajan S, Gokhale V, Groysman M, Pongtornpipat P, et al.
Oncotarget
. 2016 Mar;
7(17):23715-29.
PMID: 27009859
The anaplastic lymphoma kinase (ALK) protein drives tumorigenesis in subsets of several tumors through chromosomal rearrangements that express and activate its C-terminal kinase domain. In addition, germline predisposition alleles and...
5.
Amin A, Rajan S, Groysman M, Pongtornpipat P, Schatz J
Biomark Cancer
. 2015 Dec;
7(Suppl 2):25-32.
PMID: 26688666
Acquired resistance to targeted inhibitors remains a major, and inevitable, obstacle in the treatment of oncogene-addicted cancers. Newer-generation inhibitors may help overcome resistance mutations, and inhibitor combinations can target parallel...
6.
Amin A, Rajan S, Liang W, Pongtornpipat P, Groysman M, Tapia E, et al.
Cancer Res
. 2015 May;
75(14):2916-27.
PMID: 26018086
The anaplastic lymphoma kinase (ALK) is chromosomally rearranged in a subset of certain cancers, including 2% to 7% of non-small cell lung cancers (NSCLC) and ∼70% of anaplastic large cell...
7.
Fiema B, Harris A, Gomez A, Pongtornpipat P, Lamiman K, Vander Lugt M, et al.
J Vis Exp
. 2012 Nov;
(68).
PMID: 23149907
Unbiased discovery proteomics strategies have the potential to identify large numbers of novel biomarkers that can improve diagnostic and prognostic testing in a clinical setting and may help guide therapeutic...